[Genetic changes in chronic lymphocytic leukemia].
Chronic B-cell leukemias (CLL) are characterised by a striking cytogenetic signature composed of multiple recurrent chromosomal imbalances involving specific chromosomal regions i.e. 13q, 11q, 12q, 17p et 6q (decreasing order of frequency). These chromosomal aberrations may be found in up to 80% of the cases either as isolated or associated anomalies. They can also appear during the course of the disease suggesting their secondary nature. Furthermore, and at variance with other B-cell proliferations like lymphomas or myelomas, balanced translocations involving immunoglobulin (Ig) gene locus are rare. In addition to their interest in patient diagnosis and follow-up, these tumour-specific genetic markers also harbor important prognostic significance : isolated 13q deletions correlate with prolonged survival whereas both 17p and 11q partial deletions are independent predictors of rapid disease progression and short survival times in multivariate analyses. Genetic analyses as well as the first transcriptome studies of CLL reveal 1) a common mechanism of transformation and/or cell of origin, 2) the existence of at least two prognostic subgroups based on Ig mutational status.
Leroux
D
D
Laboratoire d'Hématologie Cellulaire et Moléculaire, Département de Biologie et Pathologie de la Cellule, Centre Hospitalier Universitaire de Grenoble, BP217, 38043 Grenoble 9, France. DLeroux@chu-grenoble.fr
Lefebvre
C
C
Callanan
M
M
D002869:Chromosome Aberrations; D017353:Gene Deletion; D006801:Humans; D007136:Immunoglobulins / Q000235:genetics; D007621:Karyotyping; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics*; D009154:Mutation; D011379:Prognosis; D014178:Translocation, Genetic
D007136:Immunoglobulins